Therefore, we tested whether inhibitory effect of NPY-I on cardiac hypertrophy is related to the miR-216b/FoxO4 pathway and inhibitory effect of miR-216b mimic and FoxO4 siRNA on cardiac hypertrophy in vitro. Here, FOXO4 is linked to cardiac hypertrophy.